Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Eukaryotic Gene Expression
Factor de Impacto: 2.156 Factor de Impacto de 5 años: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN Imprimir: 1045-4403
ISSN En Línea: 2162-6502

Volumes:
Volumen 30, 2020 Volumen 29, 2019 Volumen 28, 2018 Volumen 27, 2017 Volumen 26, 2016 Volumen 25, 2015 Volumen 24, 2014 Volumen 23, 2013 Volumen 22, 2012 Volumen 21, 2011 Volumen 20, 2010 Volumen 19, 2009 Volumen 18, 2008 Volumen 17, 2007 Volumen 16, 2006 Volumen 15, 2005 Volumen 14, 2004 Volumen 13, 2003 Volumen 12, 2002 Volumen 11, 2001 Volumen 10, 2000 Volumen 9, 1999 Volumen 8, 1998 Volumen 7, 1997 Volumen 6, 1996 Volumen 5, 1995 Volumen 4, 1994

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v18.i1.60
pages 81-91

Clinical Relevance of Transgenic Mouse Models for Aging Research

L. C. Enns
Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA
J. C. Wiley
Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA
W. C. Ladiges
Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA

SINOPSIS

Studies on transgenic mice have shown them to be useful models for human aging- and age-related diseases. Life span end points in yeast and Caenorhabditis elegans can identify highly conserved genes that promote longevity when their functions are lost and which can readily be manipulated in the mouse. Protein kinase A is an example of a highly conserved gene that has age-delaying effects when specific subunits are suppressed or removed in the mouse, suggesting that loss of function may be a rational pharmacologic target. Gain of function is also an attractive clinical approach because expression levels of some vital genes may decrease in an age-related manner. The antioxidant enzyme catalase can delay aging when the human gene is inserted into mitochondria of mice. Other antioxidant genes are of interest in this system, both individually and in combination with catalase. A challenging aspect is to determine how to deliver catalase, as well as other gene products, into the mitochondria in the clinical setting. A number of new and exciting genes will most likely be investigated as clinical antiaging targets as the result of a forward genetic life span screening approach in invertebrates and a reverse genetic life span approach in the mouse.


Articles with similar content:

Raf Kinase Inhibitory Protein (RKIP): Functional Pleiotropy in the Mammalian Brain
Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 6
Lucia Mendoza-Viveros, Hai-Ying M. Cheng, Harrod H. Ling, Neel Mehta
Ethics of End-of-Life Care: The Need for Improved Communication among Physicians, Patients, and Families
Ethics in Biology, Engineering and Medicine: An International Journal, Vol.2, 2011, issue 1
D. Passigli, S. Paul, Pamela S. Saha, Subrata Saha, R. Sarkar
Signal Processing in the Vomeronasal System: Modulation of Sexual Behavior in the Female Rat
Critical Reviews™ in Neurobiology, Vol.10, 1996, issue 3-4
Robert L. Moss, Gopalan Rajendren, Carol A. Dudley
Sirtuins in Brain Aging and Neurological Disorders
Critical Reviews™ in Eukaryotic Gene Expression, Vol.27, 2017, issue 4
Muhammad Imran Qadir, Sidra Anwar
Abstract of "Human Egg Markets: Ethical Questions on Egg Donation"
Journal of Long-Term Effects of Medical Implants, Vol.18, 2008, issue 1
Ana Lita